Mereo BioPharma Group PLC (MREO)

3.72 +0.04 (+1.09%) USD  |  NASDAQ  |  Nov 22, 16:00
3.725 0.00 (0.00%) After-Hours: 20:00
More

Mereo BioPharma Group Free Cash Flow to Equity (Quarterly)

Free Cash Flow to Equity (Quarterly) Chart

View Free Cash Flow to Equity (Quarterly) for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Free Cash Flow to Equity (Quarterly) Data

View and export this data back to 2023. Upgrade now.
Date Value
December 31, 2023 --
Date Value
September 30, 2023 --

Free Cash Flow to Equity Definition

Free cash flow to equity measures the total free cash flow divided by shareholder's equity. This metric can be used as a gauge for cash flow available for shareholders.

Read full definition.

Free Cash Flow to Equity (Quarterly) Range, Past 5 Years

Upgrade
Minimum
Dec 2023
Upgrade
Maximum
Sep 2023
Upgrade
Average
Upgrade
Median

Free Cash Flow to Equity (Quarterly) Benchmarks

TC BioPharm (Holdings) PLC --
NuCana PLC --
Biodexa Pharmaceuticals PLC --
Adaptimmune Therapeutics PLC Upgrade
DBV Technologies SA --

Free Cash Flow to Equity (Quarterly) Related Metrics

Cash from Operations (Quarterly) Upgrade
Cash from Financing (Quarterly) Upgrade
Free Cash Flow Upgrade
Free Cash Flow Per Share (Quarterly) Upgrade
Free Cash Flow Yield Upgrade